MUC1 oncoprotein blocks death receptor-mediated apoptosis by inhibiting recruitment of caspase-8.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cancer Research

• Publication date

  2008-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-08-0464PMID 18676836PMCID PMC2536759
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TRAIL signalling: decisions between life and death.

  2007cited by this paper
• Mucin 1 Oncoprotein Blocks Hypoxia-inducible Factor 1α Activation in a Survival Response to Hypoxia*

  2007cited by this paper
• MUC1 oncoprotein activates the IκB kinase β complex and constitutive NF-κB signalling

  2007cited by this paper
• MUC1 oncoprotein activates the IkappaB kinase beta complex and constitutive NF-kappaB signalling.

  2007cited by this paper
• MUC1 oncoprotein stabilizes and activates estrogen receptor alpha.

  2006cited by this paper
• cFLIP regulation of lymphocyte activation and development

  2006cited by this paper
• MUC1 Oncoprotein Functions in Activation of Fibroblast Growth Factor Receptor Signaling

  2006cited by this paper
• MUC1 oncoprotein blocks nuclear targeting of c‐Abl in the apoptotic response to DNA damage

  2006cited by this paper
• MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90

  2006cited by this paper
• MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α

  2006cited by this paper
• Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin

  2006cited by this paper
• MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin.

  2005cited by this paper
• Nonapoptotic functions of FADD-binding death receptors and their signaling molecules.

  2005cited by this paper
• Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response.

  2005cited by this paper
• MUC1 Oncoprotein Blocks Glycogen Synthase Kinase 3β–Mediated Phosphorylation and Degradation of β-Catenin

  2005cited by this paper
• The MUC1 SEA Module Is a Self-cleaving Domain*

  2005cited by this paper
• Requirement for caspase-8 in NF-kappaB activation by antigen receptor.

  2005cited by this paper
• Requirement for Caspase-8 in NF-κB Activation by Antigen Receptor

  2005cited by this paper
• Augmentation of Fas ligand-induced apoptosis by MUC1 mucin.

  2005cited by this paper
• Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents.

  2004cited by this paper
• NFκB activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP

  2004cited by this paper
• Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles.

  2004cited by this paper
• MUC1 Oncoprotein Activates the FOXO3a Transcription Factor in a Survival Response to Oxidative Stress*

  2004cited by this paper
• Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein.

  2003cited by this paper
• Nuclear association of the cytoplasmic tail of MUC1 and beta-catenin.

  2003cited by this paper
• Nuclear Association of the Cytoplasmic Tail of MUC1 and β-Catenin*

  2003cited by this paper
• Human DF3/MUC1 carcinoma-associated protein functions as an oncogene

  2003cited by this paper
• Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes.

  2003influential reference
• Human MUC1 Carcinoma Antigen Regulates Intracellular Oxidant Levels and the Apoptotic Response to Oxidative Stress*

  2003cited by this paper
• Protein kinase C delta regulates function of the DF3/MUC1 carcinoma antigen in beta-catenin signaling.

  2002cited by this paper
• ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini

  2001cited by this paper
• The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes.

  2001cited by this paper
• Covalent inhibition revealed by the crystal structure of the caspase-8/p35 complex

  2001cited by this paper
• The c-Src Tyrosine Kinase Regulates Signaling of the Human DF3/MUC1 Carcinoma-associated Antigen with GSK3β and β-Catenin*

  2001cited by this paper
• Phosphorylation of FADD/ MORT1 at Serine 194 and Association with a 70-kDa Cell Cycle-Regulated Protein Kinase1

  2000cited by this paper
• TRAIL receptor-2 signals apoptosis through FADD and caspase-8

  2000cited by this paper
• MUC1 is activated in a B-cell lymphoma by the t(1;14)(q21;q32) translocation and is rearranged and amplified in B-cell lymphoma subsets.

  2000cited by this paper
• Apoptosis signaling in lymphocytes.

  1999cited by this paper
• Interaction of Glycogen Synthase Kinase 3β with the DF3/MUC1 Carcinoma-Associated Antigen and β-Catenin

  1998cited by this paper
• Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma-associated antigen and beta-catenin.

  1998cited by this paper
• Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors.

  1998cited by this paper
• Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis.

  1998cited by this paper
• Pro-caspase-3 Is a Major Physiologic Target of Caspase-8*

  1998cited by this paper
• Death receptors: signaling and modulation.

  1998cited by this paper
• Inhibition of death receptor signals by cellular FLIP

  1997cited by this paper
• MRIT, a novel death-effector domain-containing protein, interacts with caspases and BclXL and initiates cell death.

  1997cited by this paper
• Interaction of the DF3/MUC1 Breast Carcinoma-associated Antigen and β-Catenin in Cell Adhesion*

  1997cited by this paper
• CASH, a Novel Caspase Homologue with Death Effector Domains*

  1997cited by this paper
• Caspases: the executioners of apoptosis.

  1997cited by this paper
• FLAME-1, a Novel FADD-like Anti-apoptotic Molecule That Regulates Fas/TNFR1-induced Apoptosis*

  1997cited by this paper
• Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death.

  1996cited by this paper
• FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex.

  1996cited by this paper
• Cell-associated episialin is a complex containing two proteins derived from a common precursor.

  1992cited by this paper
• Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10.

  1990cited by this paper
• Frequent alteration of the DF3 tumor-associated antigen gene in primary human breast carcinomas.

  1989cited by this paper
• Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen.

  1988influential reference
• A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats.

  1988cited by this paper
• Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast Tumors

  1984influential reference

• Immunomodulatory properties of transmembrane mucins: from chronic diseases to cancer.

  2025cites this paper
• Cardamonin anticancer effects through the modulation of the tumor immune microenvironment in triple-negative breast cancer cells.

  2024cites this paper
• The Role of MUC1 in Renal Cell Carcinoma

  2024cites this paper
• Role of Alpha-Fetoprotein in the Pathogenesis of Cancer.

  2024cites this paper
• Study on MUC20 and Tumor Association

  2024cites this paper
• Fecal miRNA profiles in colorectal cancers with mucinous morphology.

  2024cites this paper
• Galectin-3 and Epithelial MUC1 Mucin—Interactions Supporting Cancer Development

  2023cites this paper
• Clinical significance of KL-6 in immune-checkpoint inhibitor treatment for non-small cell lung cancer

  2023cites this paper
• Characterization and expression profiling of fadd gene in response to exogenous Aeromonas hydrophila or Edwardsiella tarda challenge in the hybrid yellow catfish (Pelteobagrus fulvidraco ♀ × P. vachelli ♂).

  2023cites this paper
• MUC1 attenuates neutrophilic airway inflammation in asthma by reducing NLRP3 inflammasome-mediated pyroptosis through the inhibition of the TLR4/MyD88/NF-κB pathway

  2023cites this paper
• MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy

  2022cites this paper
• Apoptotic and Necroptotic Mediators are Differentially Expressed in Mucinous and Non-Mucinous Colorectal Cancer

  2022cites this paper
• MUC1: An emerging target in cancer treatment and diagnosis.

  2022cites this paper
• The multifaceted role of MUC1 in tumor therapy resistance

  2022cites this paper
• Combined Action of Anti-MUC1 Monoclonal Antibody and Pyrazole-Platinum(II) Complexes Reveals Higher Effectiveness towards Apoptotic Response in Comparison with Monotherapy in AGS Gastric Cancer Cells

  2021cites this paper
• Cross-Talk Between Tumor Cells Undergoing Epithelial to Mesenchymal Transition and Natural Killer Cells in Tumor Microenvironment in Colorectal Cancer

  2021cites this paper
• Mucin1 and Mucin16: Therapeutic Targets for Cancer Therapy

  2021cites this paper
• MUC1 is an oncoprotein with a significant role in apoptosis (Review)

  2021influential citation
• Mucin in cancer: a stealth cloak for cancer cells

  2021cites this paper
• C1GALT1 in health and disease

  2021cites this paper
• Identification of a Programmed Cell Death-related Signature for Prediction of Osteosarcoma

  2021cites this paper
• Resistance to Cell Death in Mucinous Colorectal Cancer—A Review

  2021cites this paper
• Alpha-Fetoprotein Binding Mucin and Scavenger Receptors: An Available Bio-Target for Treating Cancer

  2021cites this paper
• Potential of Anti-MUC1 Antibodies as a Targeted Therapy for Gastrointestinal Cancers

  2020cites this paper
• Luteolin alters MUC1 extracellular domain, sT antigen, ADAM-17, IL-8, IL-10 and NF-κB expression in Helicobacter pylori-infected gastric cancer CRL-1739 cells: A preliminary study

  2020cites this paper
• MUC1 Oncoprotein Mitigates ER Stress via CDA-mediated Reprogramming of Pyrimidine Metabolism

  2020cites this paper
• The polypeptide GALNT6 Displays Redundant Functions upon Suppression of its Closest Homolog GALNT3 in Mediating Aberrant O-Glycosylation, Associated with Ovarian Cancer Progression

  2019cites this paper
• Functional Expression of Mucin1 in Human Duodenal Adenocarcinoma.

  2019cites this paper
• MUC1 downregulation promotes TNF‐α‐induced necroptosis in human bronchial epithelial cells via regulation of the RIPK1/RIPK3 pathway

  2019influential citation
• Mucin 1 downregulation impairs the anti‐necroptotic effects of glucocorticoids in human bronchial epithelial cells

  2019cites this paper
• SMAD4-independent activation of TGF-β signaling by MUC1 in a human pancreatic cancer cell line

  2018cites this paper
• MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast Cancer.

  2018cites this paper
• DDIAS suppresses TRAIL-mediated apoptosis by inhibiting DISC formation and destabilizing caspase-8 in cancer cells

  2018cites this paper
• Mucins: Structural diversity, biosynthesis, its role in pathogenesis and as possible therapeutic targets.

  2018cites this paper
• MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells

  2018cites this paper
• MUC1-C Oncoprotein Integrates a Program of EMT, Epigenetic Reprogramming and Immune Evasion in Human Carcinomas.

  2017cites this paper
• Decreased expression of MUC1 induces apoptosis and inhibits migration in pancreatic cancer PANC-1 cells via regulation of Slug pathway

  2017cites this paper
• Jujuboside A attenuates norepinephrine-induced apoptosis of H9c2 cardiomyocytes by modulating MAPK and AKT signaling pathways.

  2017cites this paper
• MUC1-C promotes the suppressive immune microenvironment in non-small cell lung cancer

  2017cites this paper
• Mucin 1, a signal transduction membrane-bound mucin, is present in human disc tissue and is downregulated in vitro by exposure to IL-1ß or TNF-α

  2017cites this paper
• Expression of the Tumor-associated Mucin 1 Epitope Analyzed with the Humanized PankoMab-GEX™ Antibody in Malignant and Normal Tissues of the Head and Neck.

  2016cites this paper
• Paradox CA 15-3 increase in metastatic breast cancer patients treated with everolimus: a change of paradigm in a case series.

  2016cites this paper
• Identification of therapeutic targets of breast cancer

  2016cites this paper
• The pro-adhesive and pro-survival effects of glucocorticoid in human ovarian cancer cells.

  2016cites this paper
• MUC1 upregulation promotes immune resistance in tumor cells undergoing brachyury-mediated epithelial-mesenchymal transition

  2016cites this paper
• Identification of FRA-1 as a novel player in pancreatic cancer in cooperation with a MUC1: ERK signaling axis

  2016cites this paper
• Computer simulation of the spatial structures of MUC1 peptides capable of inhibiting apoptosis

  2016influential citation
• The combined treatment with novel platinum(II) complex and anti-MUC1 increases apoptotic response in MDA-MB-231 breast cancer cells

  2015cites this paper
• Dynamics of p53 and Cancer

  2015cites this paper
• MUC1 as a Potential Target in Anticancer Therapies

  2015cites this paper
• Update on Mucin-1 immunotherapy in cancer: a clinical perspective

  2015cites this paper
• Mucin 1 gene silencing inhibits the growth of SMMC-7721 human hepatoma cells through Bax-mediated mitochondrial and caspase-8-mediated death receptor apoptotic pathways

  2015cites this paper
• CHD7 expression predicts survival outcomes in patients with resected pancreatic cancer.

  2014cites this paper
• Implication de la mucine membranaire MUC1 dans la progression tumorale rénale et identification de nouvelles cibles thérapeutiques

  2014cites this paper
• MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL receptor R2 expression and increasing c-FLIP expression

  2014cites this paper
• Mucins and tumor resistance to chemotherapeutic drugs.

  2014cites this paper
• Prognostic significance of mucin expression in urothelial bladder cancer.

  2014cites this paper
• MUC1 extracellular domain confers resistance of epithelial cancer cells to anoikis

  2014cites this paper
• DF3 epitope expression on MUC1 mucin is associated with tumor aggressiveness, subsequent lymph node metastasis, and poor prognosis in oral squamous cell carcinoma

  2014cites this paper
• Impact of Mucin1 knockdown on the phenotypic characteristics of the human hepatocellular carcinoma cell line SMMC-7721.

  2014cites this paper
• Anti-Tumour and Chemosensitising Effect of a Combination of Bromelain + N-Acetyl Cysteine with Cisplatin or 5-Fu on Malignant Peritoneal Mesothelioma Cells

  2013cites this paper
• ALKBH2, a novel AlkB homologue, contributes to human bladder cancer progression by regulating MUC1 expression

  2013cites this paper
• NADPH Oxidase and Nrf2 Regulate Gastric Aspiration–Induced Inflammation and Acute Lung Injury

  2013cites this paper
• THERAPEUTIC POTENTIAL OF EGFR DERIVED PEPTIDES IN BREAST CANCER

  2013cites this paper
• Investigating breast cancer O-linked glycosylation changes and their immunotherapeutic potential

  2013cites this paper
• In Silico Analysis of Compounds Characterized from Nymphaea stellata Flower with MUC1

  2013cites this paper
• Signaling from membrane mucins

  2013cites this paper
• Pancreatic Cancer - Clinical Management

  2012cites this paper
• DJ-1 inhibits TRAIL-induced apoptosis by blocking pro-caspase-8 recruitment to FADD

  2012cites this paper
• Pancreatic Cancer – Clinical Management 110 Picture 1 . Associated genes in pancreatic cancer progression

  2012cites this paper
• CA 15–3 Serum Levels in Patients with Ductal Breast Carcinoma: Relationship with Clinicopathological Parameters and Tumor Markers

  2012cites this paper
• Only in patients with hormone-dependent breast infiltrating ductal carcinomas, CA15.3 serum levels are inversely correlated with the immunohistochemical expression of Bcl2.

  2012cites this paper
• Retrospective analysis of the clinical efficacy of a dendritic cell-based cancer vaccine in patients with advanced or recurrent breast cancer

  2012cites this paper
• Relevance of MUC1 mucin in gastric carcinogenesis

  2012cites this paper
• Radioimmunotherapy in Metastatic Colorectal Cancer

  2012cites this paper
• Prevention of lung injury by Muc1 mucin in a mouse model of repetitive Pseudomonas aeruginosa infection

  2012influential citation
• MUC1c Regulates Cell Survival in Pancreatic Cancer by Preventing Lysosomal Permeabilization

  2012cites this paper
• The molecular mechanism of apoptosis upon caspase-8 activation: quantitative experimental validation of a mathematical model.

  2012cites this paper
• Immunotherapy of the Pancreatic Cancer

  2012cites this paper
• DF3 epitope expression on MUC1 mucin is associated with tumor aggressiveness, subsequent lymph node metastasis, and poor prognosis in patients with oral squamous cell carcinoma

  2012cites this paper
• MUC1 induces metastasis in esophageal squamous cell carcinoma by upregulating matrix metalloproteinase 13

  2011cites this paper
• Applying toponome imaging system for studying colon cancer

  2011cites this paper
• The diagnostic value of EMA expression in the renal parenchyma tumors.

  2011cites this paper
• Molecular targeted approaches for treatment of pancreatic cancer.

  2011cites this paper
• The diagnostic value of VEGF expression in the renal parenchyma tumors.

  2011cites this paper
• Impact of MUC1 Mucin Downregulation in the Phenotypic Characteristics of MKN45 Gastric Carcinoma Cell Line

  2011cites this paper
• Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells

  2010cites this paper
• miR-1226 targets expression of the mucin 1 oncoprotein and induces cell death.

  2010cites this paper
• The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF

  2010cites this paper
• The Tat‐conjugated N‐terminal region of mucin antigen 1 (MUC1) induces protective immunity against MUC1‐expressing tumours

  2009cites this paper
• Monoclonal antibodies in the treatment of pancreatic cancer Review

  2009cites this paper
• Array comparative genomic hybridization in retinoma and retinoblastoma tissues

  2009cites this paper
• MUC1-C oncoprotein functions as a direct activator of the nuclear factor-kappaB p65 transcription factor.

  2009cites this paper
• Mucins in cancer: function, prognosis and therapy

  2009cites this paper
• Monoclonal antibodies in the treatment of pancreatic cancer.

  2009cites this paper
• CONSTITUTIVE AND SOMATIC GENETIC EVENTS IN RETINOMA AND RETINOBLASTOMA

  2008cites this paper